Meet 6-year-old Hayk. He is a cheerful and kind little boy who loves cooking delicious meals with his mother, playing with his two older brothers, and doing sports despite the physical limitations caused by his illness.

But for more than a year now, Hayk’s childhood has been marked by pain and complicated treatment.

Since July 2025, recurrent swelling began to appear on the right side of Hayk’s face. He underwent surgery, but unfortunately the swelling continued and also affected his joints, causing severe pain and difficulty walking.

Thanks to the prescribed hormone therapy, Hayk’s condition improved to some extent, but the prolonged treatment itself led to additional health problems. On December 28, 2025, his condition worsened again and he was hospitalized. During the examinations, swelling of the omentum was also detected in the abdominal area.

In April 2026, Hayk was diagnosed with retroperitoneal fibrosis, a rare condition in which inflammatory and fibrotic changes develop.

Despite the treatment he has received so far, Hayk’s disease continues to have flare-ups. According to his treating doctors, a biological medication, rituximab (Rituximab), now needs to be added to his treatment.

The cost of the dose currently prescribed is 880,000 AMD. The need for further treatment and future dosages will be determined based on Hayk’s clinical condition and laboratory test results.

The family cannot cover this expense on their own, while it is extremely important for Hayk to continue receiving the treatment he needs.

Every donation, regardless of the amount, is an important contribution toward ensuring Hayk’s treatment.